Home>
US Stocks>
Establishment Labs Holdings Inc

Establishment Labs Holdings Inc share price today

(ESTA)

Establishment Labs Holdings Inc share price is $44.43 & ₹3,763.18

$44.43

▲

-1.57

(-3.41%)

Market is closed - opens 8 PM, 04 Dec 2024

View live Establishment Labs Holdings Inc share price in Dollar and Rupees. Guide to invest in Establishment Labs Holdings Inc from India. Also see the sentimental analysis on Indian investors investing in Establishment Labs Holdings Inc. Get details on the Indian mutual funds that are investing in Establishment Labs Holdings Inc. Get Analyst recommendations and forecasts along with all the Establishment Labs Holdings Inc's financials.

Establishment Labs Holdings Inc share price movements

$43.73
$46.49
$44.43
1.58%
Downside
Day's Volatility :5.94%
Upside
4.43%
$22.05
$60.12
$44.43
50.37%
Downside
52 Weeks Volatility :63.32%
Upside
26.1%

Establishment Labs Holdings Inc Returns

Period	Establishment Labs Holdings Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	10.07%	-6.1%	0.0%
6 Months	-14.64%	1.4%	0.0%
1 Year	88.06%	11.4%	0.0%
3 Years	-28.18%	12.9%	-18.1%

Establishment Labs Holdings Inc Key Statistics

in dollars & INR

Market Capitalization	$1.3B
Revenue TTM	$153.1M
EBITDA	$-47.9M
Earnings Per Share (EPS)	$-2.59
Profit Margin	-46.13%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-223.45%

How to invest in Establishment Labs Holdings Inc from India?

It is very easy for Indian residents to invest directly in Establishment Labs Holdings Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Establishment Labs Holdings Inc stock in both rupees (INR) and dollars (USD). Search for Establishment Labs Holdings Inc or ESTA on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Establishment Labs Holdings Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Establishment Labs Holdings Inc shares which would translate to 0.019 fractional shares of Establishment Labs Holdings Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Establishment Labs Holdings Inc

100%

Period: Sep 4, 2024 to Dec 3, 2024. Change in 30 Days versus previous period

Search volume for Establishment Labs Holdings Inc on INDmoney from India has grown in the last 30 days as on Dec 4, 2024. 100% more investors are searching Establishment Labs Holdings Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Establishment Labs Holdings Inc

JW Asset Management, LLC
11.10%
RTW INVESTMENTS, LLC
9.20%
Nantahala Capital Management, LLC
8.20%
Brown Advisory Holdings Inc
6.61%
Capital Research Global Investors
5.14%
Findell Capital Management LLC
3.57%

Analyst Recommendation on Establishment Labs Holdings Inc

Buy

92%Buy

7%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Establishment Labs Holdings Inc(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Establishment Labs Holdings Inc

What analysts predicted

Upside of 35.69%

Current:

$44.43

Target:

$60.29

Insights on Establishment Labs Holdings Inc

Decreasing Revenue
Revenue is down for the last 2 quarters, 44.11M → 40.22M (in $), with an average decrease of 8.8% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -17.18M → -16.68M (in $), with an average increase of 3.0% per quarter
Vs BSX
In the last 3 years, Boston Scientific Corp. has given 129.2% return, outperforming this stock by 156.5%

Establishment Labs Holdings Inc Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$61.2M	↑ 76.49%
Net Income	$-21.1M	↓ 39.54%
Net Profit Margin	-34.47%	↑ 66.15%

	FY19	Y/Y Change
Revenue	$89.6M	↑ 46.33%
Net Income	$-38.2M	↑ 80.82%
Net Profit Margin	-42.59%	↓ 8.12%

	FY20	Y/Y Change
Revenue	$84.7M	↓ 5.46%
Net Income	$-38.1M	↓ 0.08%
Net Profit Margin	-45.02%	↓ 2.43%

	FY21	Y/Y Change
Revenue	$126.7M	↑ 49.61%
Net Income	$-41.1M	↑ 7.92%
Net Profit Margin	-32.47%	↑ 12.55%

	FY22	Y/Y Change
Revenue	$161.7M	↑ 27.64%
Net Income	$-75.2M	↑ 82.82%
Net Profit Margin	-46.51%	↓ 14.04%

	FY23	Y/Y Change
Revenue	$165.2M	↑ 2.13%
Net Income	$-78.5M	↑ 4.38%
Net Profit Margin	-47.53%	↓ 1.02%

	Q2 FY23	Q/Q Change
Revenue	$48.6M	↑ 4.38%
Net Income	$-16.7M	↑ 40.22%
Net Profit Margin	-34.48%	↓ 8.81%

	Q3 FY23	Q/Q Change
Revenue	$38.5M	↓ 20.71%
Net Income	$-29.3M	↑ 74.82%
Net Profit Margin	-76.02%	↓ 41.54%

	Q4 FY23	Q/Q Change
Revenue	$31.6M	↓ 18.04%
Net Income	$-20.5M	↓ 29.83%
Net Profit Margin	-65.09%	↑ 10.93%

	Q1 FY24	Q/Q Change
Revenue	$37.2M	↑ 17.77%
Net Income	$-16.2M	↓ 21.13%
Net Profit Margin	-43.59%	↑ 21.5%

	Q2 FY24	Q/Q Change
Revenue	$44.1M	↑ 18.7%
Net Income	$-17.2M	↑ 6.04%
Net Profit Margin	-38.94%	↑ 4.65%

	Q3 FY24	Q/Q Change
Revenue	$40.2M	↓ 8.82%
Net Income	$-16.7M	↓ 2.9%
Net Profit Margin	-41.47%	↓ 2.53%

	FY18	Y/Y Change
Total Assets	$116.6M	↑ 104.17%
Total Liabilities	$47.1M	↓ 24.18%

	FY19	Y/Y Change
Total Assets	$116.5M	↓ 0.04%
Total Liabilities	$76.9M	↑ 63.35%

	FY20	Y/Y Change
Total Assets	$156.4M	↑ 34.2%
Total Liabilities	$81.4M	↑ 5.86%

	FY21	Y/Y Change
Total Assets	$139.5M	↓ 10.78%
Total Liabilities	$88.8M	↑ 9.04%

	FY22	Y/Y Change
Total Assets	$211.1M	↑ 51.27%
Total Liabilities	$219.2M	↑ 146.93%

	FY23	Y/Y Change
Total Assets	$268.6M	↑ 27.28%
Total Liabilities	$250.2M	↑ 14.14%

	Q2 FY23	Q/Q Change
Total Assets	$285.3M	↑ 36.27%
Total Liabilities	$230.4M	↑ 2.25%

	Q3 FY23	Q/Q Change
Total Assets	$270.5M	↓ 5.18%
Total Liabilities	$240.0M	↑ 4.17%

	Q4 FY23	Q/Q Change
Total Assets	$268.6M	↓ 0.7%
Total Liabilities	$250.2M	↑ 4.25%

	Q1 FY24	Q/Q Change
Total Assets	$301.8M	↑ 12.36%
Total Liabilities	$244.9M	↓ 2.13%

	Q2 FY24	Q/Q Change
Total Assets	$285.1M	↓ 5.55%
Total Liabilities	$240.1M	↓ 1.98%

	Q3 FY24	Q/Q Change
Total Assets	$282.7M	↓ 0.84%
Total Liabilities	$250.0M	↑ 4.13%

	FY18	Y/Y Change
Operating Cash Flow	$-33.9M	↑ 5.99%
Investing Cash Flow	$-5.7M	↑ 578.22%
Financing Cash Flow	$81.5M	↑ 89.63%

	FY19	Y/Y Change
Operating Cash Flow	$-30.0M	↓ 11.52%
Investing Cash Flow	$-7.8M	↑ 35.51%
Financing Cash Flow	$22.8M	↓ 72.05%

	FY20	Y/Y Change
Operating Cash Flow	$-12.5M	↓ 58.28%
Investing Cash Flow	$-5.6M	↓ 28.42%
Financing Cash Flow	$64.7M	↑ 183.78%

	FY21	Y/Y Change
Operating Cash Flow	$-27.5M	↑ 120.08%
Investing Cash Flow	$-7.2M	↑ 28.85%
Financing Cash Flow	$4.1M	↓ 93.73%

	FY22	Y/Y Change
Operating Cash Flow	$-52.2M	↑ 89.47%
Investing Cash Flow	$-34.8M	↑ 385.7%
Financing Cash Flow	$100.3M	↑ 2374.21%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-28.2M	↑ 36.99%
Investing Cash Flow	$-9.0M	↑ 111.52%
Financing Cash Flow	$84.5M	↑ 7042.18%

Establishment Labs Holdings Inc Technicals Summary

Sell

Neutral

Buy

Establishment Labs Holdings Inc is currently in a neutral trading position according to technical analysis indicators.

Establishment Labs Holdings Inc Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Establishment Labs Holdings Inc	-1.63%	-14.64%	88.06%	-28.18%	83.34%
Stryker Corporation	6.2%	12.61%	34.12%	53.15%	91.0%
Boston Scientific Corp.	6.74%	19.16%	64.78%	122.19%	105.15%
Edwards Lifesciences Corp.	6.11%	-19.0%	2.44%	-37.0%	-11.46%
Abbott Laboratories	-0.71%	13.16%	11.94%	-11.82%	36.65%
Medtronic Plc	-3.1%	5.14%	9.79%	-21.5%	-23.48%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Establishment Labs Holdings Inc	NA	NA	NA	-2.43	-2.23	-0.12	NA	1.16
Stryker Corporation	42.03	42.03	2.74	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	74.93	74.93	1.64	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	27.55	27.55	6.52	2.53	0.19	0.11	NA	16.18
Abbott Laboratories	36.1	36.1	2.31	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	26.38	26.38	1.56	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Establishment Labs Holdings Inc	Buy	$1.3B	83.34%	NA	-46.13%
Stryker Corporation	Buy	$149.5B	91.0%	42.03	16.34%
Boston Scientific Corp.	Buy	$133.7B	105.15%	74.93	11.26%
Edwards Lifesciences Corp.	Buy	$42.5B	-11.46%	27.55	65.86%
Abbott Laboratories	Buy	$206.3B	36.65%	36.1	13.99%
Medtronic Plc	Buy	$110.6B	-23.48%	26.38	12.06%

About Establishment Labs Holdings Inc

establishment labs is a global, privately held, high-tech medical device and aesthetics company that designs, develops, manufactures and markets an innovative product portfolio consisting of advanced silicone-filled breast and body shaping implants. with more than 30 years of advanced breast implant manufacturing experience, building quality breast implants has always been a natural outcome for establishment labs’ founders and top executives. as a result, motiva implants® has established a level of product innovation that always results in safety. and while we respect our past, we ́re more focused on the present and the future, one that ́s innovative, safe and progressive. we believe that these goals can be achieved by incorporating the current needs and preferences of plastic surgeons and patients into our product design.

Organization	Establishment Labs Holdings Inc
Employees	908
CEO	Mr. Juan Jose Chacon Quiros
Industry	Health Technology

Important FAQs about investing in Establishment Labs Holdings Inc from India :

What is Establishment Labs Holdings Inc share price today?

Establishment Labs Holdings Inc (ESTA) share price today is $44.43.

Can Indians buy Establishment Labs Holdings Inc shares?

Yes, Indians can invest in the Establishment Labs Holdings Inc (ESTA) from India.

With INDmoney, you can buy Establishment Labs Holdings Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Establishment Labs Holdings Inc at zero transaction cost.

How can I buy Establishment Labs Holdings Inc shares from India?

It is very easy to buy Establishment Labs Holdings Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Establishment Labs Holdings Inc be purchased?

Yes, you can buy fractional shares of Establishment Labs Holdings Inc with INDmoney app.

What are the documents required to start investing in Establishment Labs Holdings Inc stocks?

To start investing in Establishment Labs Holdings Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.